Search PubMed⌕ Search

Biomedical subjects

Hamphrey Ham

Publications and source records attributed to Hamphrey Ham.

26 records · Page 2Linked to original sources
PubMed2004

Interobserver reproducibility in the interpretation of captopril renograms from patients suspected of having renovascular hypertension.

This work was undertaken to identify, in hypertensive patients suspected of having renovascular hypertension (RVH), scintigraphic images and curves whose interpretation could be difficult. The baseline and postcaptopril Tc-99m MAG 3 images and curves from 10 patients clinically suspected of having RVH were retrospectively selected to have a wide sample of images and curves. The data and a multiple-choice questionnaire were presented as a PowerPoint file, which was sent electronically to Belgian nuclear medicine physicians; they had to answer if the images and curves were or were not suggestive of the diagnosis of RVH or if it was impossible to answer. There was near-complete interobserver agreement for normal baseline and postcaptopril data, for unilateral postcaptopril delayed transit and/or impaired uptake. Agreement was not as good for bilateral and symmetrical changes, for mild changes, or in cases of impaired function. This study shows that the analysis by the Internet of interobserver agreement is an easy and rapid method allowing one to identify difficult to interpret pre- and postcaptopril renographic data.

Antihypertensive Agents↗
PubMed2004

Comparison of cortical 5-HT2A receptor binding in bulimia nervosa patients and healthy volunteers.

OBJECTIVE: Bulimia nervosa has been associated with alterations in central serotonergic (5-HT) function. This study investigated iodine-labeled 4-amino-N-[1-[3-(4-fluorophenoxy) propyl]-4-methyl-4-piperidinyl]-5-iodo-2-methoxybenzamide ((123)I-5-I-R91150) binding to the 5-HT(2A) receptor in the brain by using single photon emission computed tomography in acutely ill bulimia nervosa patients. METHOD: Cortical (123)I-5-I-R91150 binding in 10 normal-weight patients with bulimia nervosa, purging type, was compared with that of 11 healthy volunteers. RESULTS: The 5-HT(2A) binding index of the bulimia nervosa patients, with and without correction for age, was not significantly different from that of the comparison group. CONCLUSIONS: As a group, acutely ill bulimia nervosa patients cannot be discriminated from healthy subjects on the basis of cortical (123)I-5-I-R91150 binding to the 5-HT(2A) receptor.

Acute Disease↗
PubMed2004

Renal toxicity after radionuclide therapy.

During the past 10 years, a variety of radiolabeled monoclonal antibodies, antibody fragments, and low-molecular- weight oncophilic peptides have been used to deliver radioactivity to target cells for therapeutic purposes. The high and persistent localization of several of these radiolabeled molecules in the kidneys raised concern about potential renal radiation toxicity compromising therapeutic effectiveness. In particular, radiolabeled peptides, such as yttrium-90-labeled synthetic somatostatin analogues, have initiated a discussion on the safety profiles of the various somatostatin derivatives in recent clinical trials. In general, the toxicity risk seems to depend on the characteristics of the oncophilic molecule, such as the molecular weight, electric charges and clearance pathways as well as the chemical and physical characteristics of the applied radionuclide. Encouraging results for the prevention of radiation-induced renal damage by radiolabeled peptides have been obtained by co-infusion of positively charged amino acids. The available literature on nephrotoxicity after radiolabeled peptide therapy is reviewed, and therapeutic options that have become available as a result of greater insights into putative pathogenic mechanisms are discussed.

Humans↗
PubMed2003

Nuclear medicine imaging for the assessment of primary and recurrent head and neck carcinoma using routinely available tracers.

This article reviews the literature on the use of fluorine-18 fluorodeoxyglucose positron emission tomography (FDG PET) and thallium-201, technetium-99m sestamibi and technetium-99m tetrofosmin single-photon emission tomography (SPET) for the diagnosis and staging of primary and recurrent squamous cell carcinoma of the head and neck (SCCHN). A search of the MEDLINE and CancerLit databases covering articles entered between 1989 and February 2003 was performed. In the case of FDG PET, only full-ring PET studies that included comparison with conventional morphological imaging were considered. Due to the wide variation in methodology, a straightforward meta-analysis of FDG PET literature was impossible. Instead, indicative summary receiver-operating curves of FDG PET and morphological imaging techniques were generated and a paired comparison of the sensitivities and specificities of FDG PET and morphological imaging performed. Compared with conventional morphological imaging, FDG PET proved as sensitive and specific for the detection of primary SCCHN but more sensitive and specific for the detection of cervical lymph node involvement (CLNI) and recurrence of SCCHN. Additional studies addressing the role of FDG PET in screening for distant metastases and synchronous primary tumours are mandatory. Following negative conventional evaluations, FDG PET identifies occult primary tumours in 20-50% of patients presenting with CLNI. As regards the use of 201Tl, 99mTc-sestamibi and 99mTc-tetrofosmin, more studies are required to define whether these imaging agents could form part of the current diagnostic armamentarium in SCCHN patients. It is concluded that FDG PET either is superior to or offers added value when compared with conventional morphological imaging techniques for the purpose of diagnosis and staging of primary and recurrent SCCHN.

Carcinoma, Squamous Cell↗
PubMed2003

When could the administration of furosemide be avoided?

PURPOSE: The purpose of this study was to evaluate whether some parameters of the basic renogram allow one to omit the administration of furosemide in cases of hydronephrosis. MATERIALS AND METHODS: One hundred thirty-seven children (274 kidneys) referred for uni- or bilateral hydronephrosis were evaluated retrospectively. In all children additional furosemide challenges followed by postmicturition views were acquired because of unsatisfactory renal emptying. The patients were categorized into 2 groups according to the residual renal activity on the postmicturition view: those with good emptying (R-) of both kidneys, for which the administration of furosemide was considered of no influence, and those with partial or no emptying of at least 1 kidney (R+). The renogram parameters chosen for predicting R+ and R- were time to maximum (Tmax), output efficiency at 20 minutes (OE20), and normalized residual activity at 20 minutes (NORA20). For each parameter, the number of children was then calculated, for whom the administration of furosemide could have been omitted. RESULTS: A total of 112 children were categorized as R- and 25 as R+. The cutoff values for 100% negative predictive value of Tmax, OE20, and NORA20 were 4.5 minutes, 66%, and 1.45 respectively. Application of these cutoff values for the parameters yields, in retrospect, 6 (4%), 29 (21%), and 22 (16%) children respectively for whom administration of furosemide could have been omitted. CONCLUSION: On the basis of OE20 and NORA20, the administration of furosemide could have been omitted in a substantial number of patients, despite unsatisfactory renal emptying on the basic renogram.

Case-Control Studies↗
PubMed2002

Normalized residual activity: usual values and robustness of the method.

UNLABELLED: The objectives of this study were 2-fold: first, to investigate the robustness of the normalized residual activity (NORA), a parameter that has recently been proposed for the estimation of renal emptying during renography; and second, to define the usual values of NORA in 2 categories of kidneys-those with a normal renogram and those that are dilated but definitely unobstructed. METHODS: NORA was defined as the renal activity at a given moment (end of renogram, end of furosemide acquisition, image after micturition) divided by the renal activity between 1 and 2 min. Two variables that might influence the results of NORA were evaluated: the choice of background correction, and an error in the estimation of the 1- to 2-min renal activity. To estimate the values of NORA in usual clinical conditions, 2 sets of data were analyzed: normal kidneys with a normal renogram pattern, and dilated but definitely unobstructed kidneys. RESULTS: Using a perirenal or a subrenal background correction, NORA was, on average, 67% or 83%, respectively, of the value obtained without background correction. The use of a renal activity of 1 min 20 s to 2 min 20 s instead of a 1- to 2-min activity resulted in a systematic 10%-15% underestimation of NORA. The 90th percentile values of NORA were, in the normal group, 0.70 at 20 min, 0.23 at the end of the furosemide test, and 0.10 after micturition. In the kidneys that had undergone surgery, the 90th percentile values were 3.92 at 20 min, 2.91 at the end of the furosemide test, and 1.99 after micturition. A good correlation was observed between NORA and output efficiency. CONCLUSION: If adequately standardized, NORA is a robust and simple parameter that allows evaluation of renal emptying at any time of the acquisition. One should be aware of the fact that high NORA values, corresponding to poor renal emptying, may be observed in the operated unobstructed kidneys, even after micturition.

Adult↗